Yang et al., 2016 - Google Patents
The oxidative burst system in amphioxusYang et al., 2016
- Document ID
- 8836910741212136463
- Author
- Yang P
- Huang S
- Xu A
- Publication year
- Publication venue
- Amphioxus Immunity
External Links
Snippet
In this chapter, we examine the components of the amphioxus NOX system. Amphioxus contains all key components of the NOX system. Functional analyses have shown that these components are able to form a functional phagocytic respiratory burst pathway required for …
- 241000251522 Cephalochordata 0 title abstract description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Geiszt | NADPH oxidases: new kids on the block | |
| Roos et al. | Oxidative killing of microbes by neutrophils | |
| Babior | NADPH oxidase: an update | |
| Sirokmány et al. | Nox/Duox family of NADPH oxidases: lessons from knockout mouse models | |
| Spencer et al. | The basic biology of redoxosomes in cytokine-mediated signal transduction and implications for disease-specific therapies | |
| Cheng et al. | Identification and characterization of VPO1, a new animal heme-containing peroxidase | |
| Kuroda et al. | The superoxide‐producing NAD (P) H oxidase Nox4 in the nucleus of human vascular endothelial cells | |
| Bayraktutan et al. | Expression of a functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells | |
| Giardino et al. | NADPH oxidase deficiency: a multisystem approach | |
| Segal | The NADPH oxidase and chronic granulomatous disease | |
| Cifuentes et al. | Targeting reactive oxygen species in hypertension | |
| Park et al. | Sequential activation of phosphatidylinositol 3-kinase, βPix, Rac1, and Nox1 in growth factor-induced production of H2O2 | |
| Deshane et al. | Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism | |
| Le Scolan et al. | Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression | |
| Quinn et al. | Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases | |
| Kawahara et al. | Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells | |
| Tan et al. | Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase | |
| Diebold et al. | NOX2 as a target for drug development: indications, possible complications, and progress | |
| Orient et al. | Novel sources of reactive oxygen species in the human body | |
| Roos et al. | Chronic granulomatous disease | |
| Dang et al. | The dual role of reactive oxygen species-generating nicotinamide adenine dinucleotide phosphate oxidases in gastrointestinal inflammation and therapeutic perspectives | |
| Yang et al. | The oxidative burst system in amphioxus | |
| EP2616484B1 (en) | Screening method | |
| Kim et al. | Redox regulation of lipopolysaccharide-mediated sulfiredoxin induction, which depends on both AP-1 and Nrf2 | |
| Yang et al. | The microbicidal and cytoregulatory roles of NADPH oxidases |